Day: April 3, 2020

MORRIS PLAINS, N.J., April 03, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that the Company will host a conference call and live audio webcast on Monday, April 6, 2020 at 8:00 a.m. Eastern Time to provide a clinical development and general corporate update.  To access the conference call, please dial (877) 303-2523 or (253) 237-1755 using the Conference ID 8348877. The conference call will be webcast via the Investors page on the Company’s website at https://immunomedics.com/investors/. Approximately two hours following the live event, a webcast replay of the conference call will be available on the Company’s website for approximately 30 days.About ImmunomedicsImmunomedics is a clinical-stage...

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.TORONTO, April 03, 2020 (GLOBE NEWSWIRE) — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) announces, further to its news release of March 13, 2020, that the Company’s principal regulator, the Ontario Securities Commission (the “Commission”), granted a management cease trade order (the “MCTO”) on March 31, 2020, under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“). Pursuant to the MCTO, the Chief Executive Officer and the Chief Financial Officer may not trade in securities of the Company until such time as the Company files its annual audited financial statements for...

VANCOUVER, British Columbia, April 03, 2020 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc.  (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF), a growth oriented and diversified international cannabis company, is pleased to announce its key asset, Propagation Services Canada (the “Delta Facility”) has completed additional steps in the process to obtain a license to cultivate cannabis from Health Canada and confirms its commitment to deliver the cultivation license at the Delta Facility prior to the end of Q2 2020, barring any material change in Health Canada’s service standards as a result of prevailing socioeconomic conditions.On April 3rd 2020, the Delta Facility submitted responses to the third request for more information (the “RMI”) from Health Canada with respect to its cultivation application. ...

TORONTO, April 03, 2020 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX-V:ERE.UN, “ERES”) announced today that it has secured mortgage financing on its December 16, 2019 acquisition of a Netherlands property (the “Kameleon Property”) in the principal amount of €18.7 million for the retail portion and €44.3 million for the residential portion. The facilities agreement was executed on March 27, 2020, and provides the retail tranche with a 4-year term to maturity and the residential tranche with a 7-year term to maturity, with proceeds expected by late April 2020.

Phase 1b trial with AM-201 proceeding as planned to data read-out in early May 2020Enrollment into Phase 2 trial with AM-125 impacted by COVID-19 pandemicCompany to report 2019 second-half and full year results and provide general business update on April 16, 2020  Hamilton, Bermuda, April 3, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today provided an update on the impact of the COVID-19 pandemic on its ongoing clinical trials with intranasal betahistine.The Phase 1b trial with AM-201, intranasal betahistine for the prevention of antipsychotic-induced weight gain and somnolence, has remained unaffected by the COVID-19 pandemic. The last subject had its last treatment visit...

San Antonio, TX, April 03, 2020 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”) is pleased to announce significant inflows into its U.S. Global Jets ETF (JETS), with assets under management (AUM) jumping more than $250 million in the first quarter of 2020, from $52 million at the end of 2019 to $302 million as of March 31. Total AUM in the Company complex rose approximately 20 percent for the quarter.JETS reached another exciting new milestone recently. Daily trading volume for the airlines ETF crossed above 5 million shares for the first time ever on March 25. This represents a substantial increase from the same time a year earlier, when daily volume was approximately 11,700 shares. As of April 2, the average 30-day trading volume for JETS was 2 million. Airlines Critical to the U.S. and Global Economy As...

AUSTIN, Texas, April 03, 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) and BioBridge Global today announced their collaboration to participate in a U.S. Food and Drug Administration (FDA) investigational program for U.S. blood centers to begin collecting and distributing convalescent plasma from individuals who have recovered from COVID-19.In working toward a potential treatment for COVID-19 patients, XBiotech has developed a clinical test that QualTex Laboratories, a subsidiary of San Antonio-based nonprofit BioBridge Global, will use to identify natural antibodies present in human blood that work against the virus that causes COVID-19. The testing technology will allow QualTex to identify blood that contains naturally neutralizing antibodies against the virus in patients who have recovered from COVID-19 (convalescent donors).Plasma...

MOUNTAIN GROVE, Mo., April 03, 2020 (GLOBE NEWSWIRE) — First Bancshares, Inc. (OTCPink – FstBksh: FBSI) (“Company”), the holding company for Stockmens Bank ), today announced a change to the venue of its annual meeting of shareholders.Due to the emerging public health impact of the coronavirus outbreak (COVID-19) and to support the health and well-being of our employees, shareholders, and our community the location of the 2020 Annual Meeting of Shareholders has been changed and will be held over the web in a virtual meeting format only.If you were a shareholder as of the close of business on March 20, 2020 and have your control number, you may vote during the Annual Meeting by following the instructions available on your proxy card. For a registered shareholder, the control number can be found on your proxy card or notice, or...

VANCOUVER, British Columbia, April 03, 2020 (GLOBE NEWSWIRE) — FIRST MAJESTIC SILVER CORP. (the “Company” or “First Majestic”) today announced that operations at its San Dimas, Santa Elena and La Encantada mines in Mexico will be temporarily suspended in accordance with Mexico’s Ministry of Health’s Decree to mitigate the spread and transmission of COVID-19.On March 31, 2020, the Ministry of Health issued the Decree requiring non-essential businesses, including mining, to temporarily suspend activities until April 30, 2020. Since the Decree was announced, the Company has been working with local and state officials, industry task force groups and other mining companies to make the case to the Federal Government that mining, especially silver mining, is essential and critical to the medical industry given silver’s antibacterial...

MINNEAPOLIS, MN, April 03, 2020 (GLOBE NEWSWIRE) —  Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced it will pause enrollment in its ongoing clinical trial of SBP-101.The COVID-19 pandemic has affected the conduct of clinical trials at our US and Australian sites. Some cancer centers have redeployed resources to prioritize COVID-19 patient care activities.Michael T. Cullen, MD, MBA, Sun BioPharma’s President and CEO, noted today the Company would follow the lead of other pharmaceutical companies in instituting a recruitment delay of new patients in its current Phase 1 dose escalation and expansion study of SBP-101 in combination with nab-paclitaxel and gemcitabine in subjects with previously untreated metastatic...